Short communicationPublished 14 Mar 2018
Survey of HAART/ART in HIV/AIDS Patients
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Human immunodeficiency virus (HIV) has progressed from a fatal to chronic disease due to the almost universal use and accessibility of antiretroviral therapy (ART) in HIV-infected patients. Antiretroviral (ARV) treatment works by suppressing the viral load and restoring the immune system. Once patients start highly active antiretroviral therapy (HAART), it must be continued throughout life despite its many unwanted side effects. Zidovudine (AZT) a nucleoside reverse transcriptase inhibitor is the first-line antiretroviral regimen in India and was the first breakthrough in AIDS therapy in 1990. It is known to be associated with life-threatening toxicity like anaemia.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Toxicology
- SubjectPharmaceutical Sciences
- SubjectToxicology
- BylineArticles whose byline prints “Rajeev R Shah”
- BylineArticles whose byline prints “Reena Mehta”